1
Yu Momose, Tsuyoshi Maekawa, Tomoko Asakawa, Nozomu Sakai: Isoxazole derivatives. Takeda Pharmaceutical Company, Elaine M Ramesh, Mark Chao, April 4, 2006: US07022725 (17 worldwide citation)

A compound represented by the formula (I) wherein one of R1 and R2 is a hydrogen atom or a substituent and the other is an optionally substituted cyclic group; W is a bond or a divalent aliphatic hydrocarbon group; Y is a group of the formula: —OR3 (wherein R3 is a hydrogen atom, an optionally subst ...


2
Yu Momose, Hiroyuki Odaka, Hiroshi Imoto, Hiroyuki Kimura, Junichi Sakamoto: Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity. Takeda Chemical, Philippe Y Riesen, June 26, 2001: US06251926 (14 worldwide citation)

This invention provides a novel oxyiminoalkanoic acid derivative which has excellent hypoglycemic and hypolipidemic actions and which is used for the treatment of diabetes mellitus, hyperlipemia, insulin insensitivity, insulin resistance and impaired glucose tolerance.


3
Takashi Sohda, Zen ichi Terashita, Yu Momose, Yukio Fujisawa, Junji Mizoguchi: Condensed thiadiazole derivative, method of its production, and use thereof. Takeda Chemical, Foley & Lardner, August 27, 1996: US05550138 (13 worldwide citation)

(1) a compound represented by the following formula (I): ##STR1## wherein R represents a hydrocarbon group or heterocyclic group which may be substituted; the ring A represents a pyridine ring having a substituent or a thiazole ring which may be substituted; or a pharmaceutically acceptable salt the ...


4
Takashi Sohda, Hitoshi Ikeda, Yu Momose: Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents. Takeda Chemical, Wegner Cantor Mueller & Player, August 24, 1993: US05239080 (12 worldwide citation)

Oxazole compounds having the formula: ##STR1## in which A is a group of the formula --CH.sub.2 OR.sup.3 (R.sup.3 is a hydrogen atom, an optionally substituted hydrocarbon residue, an optionally substituted heterocyclic group or an acyl group), or an aldehyde group and B is an optionally substituted ...


5
Takashi Sohda, Hiroyuki Odaka, Yu Momose, Mitsuru Kawada: Oxazolidinedione derivatives, their production and use. Takeda Chemical, Wenderoth Lind & Ponack L, August 3, 1999: US05932601 (10 worldwide citation)

2,4-Oxazolidinedione derivative represented by the formula: ##STR1## wherein R stands for an optionally substituted hydrocarbon residue or heterocyclic group; Y stands for a group represented by --CO--, --CH(OH)-- or --NR.sup.3 -- (wherein R.sup.3 stands for an optionally substituted alkyl group); m ...


6
Yu Momose, Katsuhito Murase: Neurotrophin production secretion promoting agent. Takeda Chemical, Mark Chao, Elaine M Ramesh, August 12, 2003: US06605629 (10 worldwide citation)

A neurotrophin production/secretion promoting agent which comprises an azole derivative of the formula:


7

8
Takashi Sohda, Hiroyuki Odaka, Yu Momose: Thiazolidinedione derivatives, their production and use. Takeda Chemical, Wenderoth Lind & Ponack L, October 12, 1999: US05965589 (9 worldwide citation)

A 2,4-thiazolidinedione derivative of the formula (I): ##STR1## wherein R is an optionally substituted hydrocarbon group or heterocyclic group which may be attached through a hydrocarbon chain; n is 0 or 1; X is CH or N; Y is a bivalent hydrocarbon group; R.sup.1 and R.sup.2 are the same or differen ...


9
Takashi Sohda, Hitoshi Ikeda, Yu Momose, Sachiko Imai: Oxazolidinedione derivatives and their use. Takeda Chemical, Wenderoth Lind & Ponack, September 9, 1997: US05665748 (9 worldwide citation)

Novel 2,4-oxazolidinedione compounds of the formula: ##STR1## wherein R is a hydrocarbon residue or a heterocyclic group each of which may be substituted; Y is --CO--, --CH(OH)-- or --NR.sup.3 -- (wherein R.sup.3 is an alkyl group which may be substituted); m is 0 or 1; n is 0, 1 or 2; X is CH or N; ...


10
Yu Momose, Nobuyuki Takakura, Tsuyoshi Maekawa, Hiroyuki Odaka, Hiroyuki Kimura: Five-membered heterocyclic compounds. Takeda Pharmaceutical Company, Finnegan Henderson Farabow Garrett & Dunner, May 6, 2008: US07368578 (8 worldwide citation)

The present invention provides a compound represented by the formula: wherein R1 is an optionally substituted 5-membered heterocyclic group; X, Y and V are the same or different and each is a bond, an oxygen atom, a sulfur atom and the like; Q is a divalent hydrocarbon group having 1 to 20 carbon at ...